Evidence map›Paper›PMID 30266961›Full record

ArticleScientific reports2018

High-affinity IgM

Yasuyuki Tashiro, Akikazu Murakami, Yasushi Hara, Takeyuki Shimizu, Masato Kubo, Ryo Goitsuka, Hidehiro Kishimoto, Takachika Azuma

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.1field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Yasuyuki TashiroDivision of Development and Aging, Research Institute for Biomedical Sciences, Tokyo University of Science, Noda, Chiba, Japan. ta.yasuyuki@gmail.com.
Akikazu MurakamiDepartment of Parasitology & Immunopathoetiology, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.
Yasushi HaraShared equipment room, Research Institute for Biomedical Sciences, Tokyo University of Science, Noda, Chiba, Japan.ORCID http://orcid.org/0000-0002-0528-3252
Takeyuki ShimizuDepartment of Immunology, Kochi Medical School, Kochi University, Kochi, Japan.
Masato KuboDivision of Molecular Pathology, Research Institute for Biomedical Sciences, Tokyo University of Science, Noda, Chiba, Japan.
Ryo GoitsukaDivision of Development and Aging, Research Institute for Biomedical Sciences, Tokyo University of Science, Noda, Chiba, Japan.ORCID http://orcid.org/0000-0002-1137-9760
Hidehiro KishimotoDepartment of Parasitology & Immunopathoetiology, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.
Takachika AzumaDivision of Biosignaling, Research Institute for Biomedical Sciences, Tokyo University of Science, Noda, Chiba, Japan.
Tokyo University of Science · JPUniversity of the Ryukyus · JPKōchi University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IgM antibodies (Abs) are thought to play a major role in humoral immunity but only at the early stage of the primary immune response. However, two subsets of IgM

Indexed as

AnimalsAntibody-Producing CellsB-LymphocytesCell DifferentiationCells, CulturedChickensImmunoglobulin GImmunoglobulin MImmunologic MemoryLymphocyte ActivationMice, Inbred C57BLT-LymphocytesImmunoglobulin GImmunoglobulin M

Identifiers

PMID30266961
PMCPMC6162211
OpenAlexW2893349499

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.